annual report thursday 22nd august, page-2

As I understand it and no-doubt, at best, I'm only partially correct - metabolic final testing of trial subjects is in October, so don't think there'll be any specific news on that front until Nov/Dec - but to be fair, that is what MSB has previously indicated, initial outcomes likely before end of year.

Interestingly though, the initiation of their PhII trial in kidney dysfunction really gives already great insight, I think anyway, it certainly confirms underlying safety thinking by both MSB and regulators - so effectively that box is already ticked!

Regardless if it's tomorrow, next week, next month, the reality is a BIG day is fast approaching for MSB! Yes, PhIII cardio announcement time-frame is proving frustrating, but otherwise MSB is right on track.

As many have regularly commented, MSB is A LOT more than a one trick [cardio] pony and it's important we don't forget that, because these other apps are moving along nicely - in my opinion and always DYOR!

Happy weekend to all...